{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:37:56Z","timestamp":1788183476308,"version":"build-2803163510"},"reference-count":283,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007579","name":"Auburn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["14SDG20400015"],"award-info":[{"award-number":["14SDG20400015"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.phrs.2019.04.029","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T11:08:18Z","timestamp":1556363298000},"page":"279-291","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Neuroinflammation in hypertension: the renin-angiotensin system versus pro-resolution pathways"],"prefix":"10.1016","volume":"144","author":[{"given":"Francesca Elisabeth","family":"Mowry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinicia Campana","family":"Biancardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.018912","article-title":"Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries","volume":"134","author":"Mills","year":"2016","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.phrs.2019.04.029_bib0010","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCRESAHA.118.312156","article-title":"Treatment of Resistant and Refractory Hypertension","volume":"124","author":"Acelajado","year":"2019","journal-title":"Circ Res."},{"key":"10.1016\/j.phrs.2019.04.029_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.117.08936","article-title":"Recent Advances in Neurogenic Hypertension: Dietary Salt, Obesity, and Inflammation","author":"Stocker","year":"2017","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.phrs.2019.04.029_bib0020","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.cellsig.2014.06.011","article-title":"A century old renin-angiotensin system still grows with endless possibilities: AT1 receptor signaling cascades in cardiovascular physiopathology","volume":"26","author":"Balakumar","year":"2014","journal-title":"Cell Signal."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0025","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11906-018-0810-1","article-title":"Integrative Physiological Aspects of Brain RAS in Hypertension","volume":"20","author":"de Morais","year":"2018","journal-title":"Curr Hypertens Rep."},{"issue":"4613","key":"10.1016\/j.phrs.2019.04.029_bib0030","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.6879184","article-title":"Angiotensin synthesis in the brain and increased turnover in hypertensive rats","volume":"221","author":"Ganten","year":"1983","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.phrs.2019.04.029_bib0035","doi-asserted-by":"crossref","first-page":"13415","DOI":"10.1073\/pnas.96.23.13415","article-title":"Aminopeptidase A inhibitors as potential central antihypertensive agents","volume":"96","author":"Reaux","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"6 Pt 2","key":"10.1016\/j.phrs.2019.04.029_bib0040","first-page":"II-14","article-title":"Renin-like activity in the rat brain during the development of DOC-salt hypertension","volume":"3","author":"Basso","year":"1981","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2019.04.029_bib0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12974-015-0306-8","article-title":"Brain inflammation and hypertension: the chicken or the egg?","volume":"12","author":"Winklewski","year":"2015","journal-title":"J Neuroinflammation"},{"issue":"11","key":"10.1016\/j.phrs.2019.04.029_bib0050","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1073\/pnas.85.11.4095","article-title":"Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide","volume":"85","author":"Schiavone","year":"1988","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"14","key":"10.1016\/j.phrs.2019.04.029_bib0055","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2 Pt 2","key":"10.1016\/j.phrs.2019.04.029_bib0060","first-page":"I153","article-title":"Converting enzyme activity and angiotensin metabolism in the dog brainstem","volume":"11","author":"Santos","year":"1988","journal-title":"Hypertension"},{"issue":"1 Pt 2","key":"10.1016\/j.phrs.2019.04.029_bib0065","first-page":"H324","article-title":"Cardiovascular effects of angiotensin-(1-7) injected into the dorsal medulla of rats","volume":"257","author":"Campagnole-Santos","year":"1989","journal-title":"Am J Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0070","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1124\/pr.113.008136","article-title":"MAS and its related G protein-coupled receptors","volume":"66","author":"Bader","year":"2014","journal-title":"Mrgprs. Pharmacol Rev."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0075","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol Rev."},{"issue":"3\u20134","key":"10.1016\/j.phrs.2019.04.029_bib0080","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00424-017-1942-x","article-title":"Macrophages in neuroinflammation: role of the renin-angiotensin-system","volume":"469","author":"Hammer","year":"2017","journal-title":"Pflugers Arch."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0085","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0889-857X(03)00117-0","article-title":"Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entree for resoleomics","volume":"30","author":"Serhan","year":"2004","journal-title":"Rheum Dis Clin North Am."},{"issue":"20","key":"10.1016\/j.phrs.2019.04.029_bib0090","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2011.06.063","article-title":"Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events","volume":"58","author":"Mozaffarian","year":"2011","journal-title":"J Am Coll Cardiol."},{"issue":"8","key":"10.1016\/j.phrs.2019.04.029_bib0095","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd.2016.39","article-title":"Resolution of inflammation: a new therapeutic frontier","volume":"15","author":"Fullerton","year":"2016","journal-title":"Nat Rev Drug Discov."},{"issue":"12","key":"10.1016\/j.phrs.2019.04.029_bib0100","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/ni1276","article-title":"Resolution of inflammation: the beginning programs the end","volume":"6","author":"Serhan","year":"2005","journal-title":"Nat Immunol."},{"issue":"7203","key":"10.1016\/j.phrs.2019.04.029_bib0105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature07201","article-title":"Origin and physiological roles of inflammation","volume":"454","author":"Medzhitov","year":"2008","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/HYPERTENSIONAHA.111.182154","article-title":"Angiotensin II-induced hypertension is modulated by nuclear factor-kappaBin the paraventricular nucleus","volume":"59","author":"Cardinale","year":"2012","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0115","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.taap.2013.12.001","article-title":"Chronic infusion of enalaprilat into hypothalamic paraventricular nucleus attenuates angiotensin II-induced hypertension and cardiac hypertrophy by restoring neurotransmitters and cytokines","volume":"274","author":"Kang","year":"2014","journal-title":"Toxicol Appl Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.110.150409","article-title":"Brain microglial cytokines in neurogenic hypertension","volume":"56","author":"Shi","year":"2010","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0125","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/cvr\/cvp073","article-title":"Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension","volume":"82","author":"Kang","year":"2009","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.phrs.2019.04.029_bib0130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.taap.2017.08.012","article-title":"Central administration of tert-butylhydroquinone attenuates hypertension via regulating Nrf2 signaling in the hypothalamic paraventricular nucleus of hypertensive rats","volume":"333","author":"Bai","year":"2017","journal-title":"Toxicol Appl Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0135","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/CIRCRESAHA.109.208439","article-title":"Angiotensin II inhibits neuronal nitric oxide synthase activation through the ERK1\/2-RSK signaling pathway to modulate central control of blood pressure","volume":"106","author":"Cheng","year":"2010","journal-title":"Circ Res."},{"issue":"12","key":"10.1016\/j.phrs.2019.04.029_bib0140","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat Med."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0145","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1124\/pr.117.014647","article-title":"Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions","volume":"70","author":"Erickson","year":"2018","journal-title":"Pharmacol Rev."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-Brain Barrier: From Physiology to Disease and Back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol Rev."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0155","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000211202","article-title":"Angiotensinergic regulation of autonomic and neuroendocrine outputs: critical roles for the subfornical organ and paraventricular nucleus","volume":"89","author":"Ferguson","year":"2009","journal-title":"Neuroendocrinology"},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0160","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1357-2725(02)00306-0","article-title":"The brain renin-angiotensin system: location and physiological roles","volume":"35","author":"McKinley","year":"2003","journal-title":"Int J Biochem Cell Biol."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0165","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/HYPERTENSIONAHA.113.01743","article-title":"Circulating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier","volume":"63","author":"Biancardi","year":"2014","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0170","doi-asserted-by":"crossref","first-page":"H404","DOI":"10.1152\/ajpheart.00247.2015","article-title":"Cross talk between AT1 receptors and Toll-like receptor 4 in microglia contributes to angiotensin II-derived ROS production in the hypothalamic paraventricular nucleus","volume":"310","author":"Biancardi","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0175","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1113\/EP086434","article-title":"The role of the blood-brain barrier in hypertension","volume":"103","author":"Setiadi","year":"2018","journal-title":"Exp Physiol."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0180","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/HYPERTENSIONAHA.109.142836","article-title":"Brain perivascular macrophages and the sympathetic response to inflammation in rats after myocardial infarction","volume":"55","author":"Yu","year":"2010","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0185","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1113\/expphysiol.2008.045948","article-title":"Mineralocorticoid receptors, inflammation and sympathetic drive in a rat model of systolic heart failure","volume":"95","author":"Felder","year":"2010","journal-title":"Exp Physiol."},{"key":"10.1016\/j.phrs.2019.04.029_bib0190","doi-asserted-by":"crossref","first-page":"s1321","DOI":"10.2741\/1211","article-title":"Signaling the brain in systemic inflammation: the role of perivascular cells","volume":"8","author":"Schiltz","year":"2003","journal-title":"Front Biosci."},{"issue":"12","key":"10.1016\/j.phrs.2019.04.029_bib0195","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1172\/JCI86950","article-title":"Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension","volume":"126","author":"Faraco","year":"2016","journal-title":"J Clin Invest."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0200","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/glia.1105","article-title":"Central nervous system perivascular cells are immunoregulatory cells that connect the CNS with the peripheral immune system","volume":"36","author":"Williams","year":"2001","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0205","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12012-012-9184-9","article-title":"Renin-angiotensin system modulates neurotransmitters in the paraventricular nucleus and contributes to angiotensin II-induced hypertensive response","volume":"13","author":"Qi","year":"2013","journal-title":"Cardiovasc Toxicol."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0210","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/npp.2010.225","article-title":"Angiotensin II AT1 receptor blockade ameliorates brain inflammation","volume":"36","author":"Benicky","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"6-7","key":"10.1016\/j.phrs.2019.04.029_bib0215","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10571-009-9368-4","article-title":"Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery","volume":"29","author":"Benicky","year":"2009","journal-title":"Cell Mol Neurobiol."},{"key":"10.1016\/j.phrs.2019.04.029_bib0220","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.autneu.2014.10.001","article-title":"Pro-inflammatory cytokines in paraventricular nucleus mediate the cardiac sympathetic afferent reflex in hypertension","volume":"186","author":"Shi","year":"2014","journal-title":"Auton Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0225","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/HYPERTENSIONAHA.111.169748","article-title":"Autonomic-immune-vascular interaction: an emerging concept for neurogenic hypertension","volume":"57","author":"Zubcevic","year":"2011","journal-title":"Hypertension"},{"issue":"45","key":"10.1016\/j.phrs.2019.04.029_bib0230","doi-asserted-by":"crossref","first-page":"17587","DOI":"10.1523\/JNEUROSCI.3241-13.2013","article-title":"How do immune cells support and shape the brain in health, disease, and aging?","volume":"33","author":"Schwartz","year":"2013","journal-title":"J Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0235","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI58644","article-title":"Innate immunity in the central nervous system","volume":"122","author":"Ransohoff","year":"2012","journal-title":"J Clin Invest."},{"key":"10.1016\/j.phrs.2019.04.029_bib0240","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev-physiol-022516-034406","article-title":"Microglia in Physiology and Disease","volume":"79","author":"Wolf","year":"2017","journal-title":"Annu Rev Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0245","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.00042.2016","article-title":"Physiology of Astroglia","volume":"98","author":"Verkhratsky","year":"2018","journal-title":"Physiol Rev."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib0250","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrn3898","article-title":"Astrocyte barriers to neurotoxic inflammation","volume":"16","author":"Sofroniew","year":"2015","journal-title":"Nat Rev Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0255","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2019.04.029_bib0260","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","article-title":"Neuroinflammation in schizophrenia-related psychosis: a PET study","volume":"50","author":"Doorduin","year":"2009","journal-title":"J Nucl Med."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0265","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","article-title":"Mechanisms underlying inflammation in neurodegeneration","volume":"140","author":"Glass","year":"2010","journal-title":"Cell"},{"issue":"1-2","key":"10.1016\/j.phrs.2019.04.029_bib0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.07.012","article-title":"Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases","volume":"274","author":"Gonzalez","year":"2014","journal-title":"J Neuroimmunol."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0275","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0280","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1007\/s12035-017-0754-5","article-title":"Angiotensin Receptor Blockade by Inhibiting Glial Activation Promotes Hippocampal Neurogenesis Via Activation of Wnt\/beta-Catenin Signaling in Hypertension","volume":"55","author":"Bhat","year":"2018","journal-title":"Mol Neurobiol."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.08.013","article-title":"Role of neuroinflammation in hypertension-induced brain amyloid pathology","volume":"33","author":"Carnevale","year":"2012","journal-title":"Neurobiol Aging."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib0290","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1046\/j.1471-4159.2003.01634.x","article-title":"Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia","volume":"84","author":"Carreno-Muller","year":"2003","journal-title":"J Neurochem."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0295","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s11481-016-9703-8","article-title":"Angiotensin Converting Enzyme Inhibitors Ameliorate Brain Inflammation Associated with Microglial Activation: Possible Implications for Alzheimer\u2019s Disease","volume":"11","author":"Torika","year":"2016","journal-title":"J Neuroimmune Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2019.04.029_bib0300","doi-asserted-by":"crossref","first-page":"e92937","DOI":"10.1371\/journal.pone.0092937","article-title":"Direct pro-inflammatory effects of prorenin on microglia","volume":"9","author":"Shi","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0305","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/HYPERTENSIONAHA.115.05333","article-title":"Microglia participate in neurogenic regulation of hypertension","volume":"66","author":"Shen","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0310","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/HYPERTENSIONAHA.116.07747","article-title":"Astrocytes Contribute to Angiotensin II Stimulation of Hypothalamic Neuronal Activity and Sympathetic Outflow","volume":"68","author":"Stern","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2019.04.029_bib0315","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fncel.2014.00112","article-title":"Neuroinflammation in the pathogenesis of Alzheimer\u2019s disease. A rational framework for the search of novel therapeutic approaches","volume":"8","author":"Morales","year":"2014","journal-title":"Front Cell Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib0320","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol."},{"issue":"5566","key":"10.1016\/j.phrs.2019.04.029_bib0325","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1126\/science.1071059","article-title":"The danger model: a renewed sense of self","volume":"296","author":"Matzinger","year":"2002","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib0330","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.phrs.2019.04.029_bib0335","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.phrs.2017.03.017","article-title":"The interplay between Angiotensin II, TLR4 and hypertension","volume":"120","author":"Biancardi","year":"2017","journal-title":"Pharmacol Res."},{"issue":"7","key":"10.1016\/j.phrs.2019.04.029_bib0340","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.phrs.2019.04.029_bib0345","article-title":"Targeting TLR4 signaling pathways: can therapeutics pay the toll for hypertension?","author":"Nunes","year":"2018","journal-title":"Br J Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0350","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/08830185.2016.1261318","article-title":"Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells","volume":"36","author":"Tartey","year":"2017","journal-title":"Int Rev Immunol."},{"issue":"9","key":"10.1016\/j.phrs.2019.04.029_bib0355","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/CS20110164","article-title":"Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential","volume":"121","author":"Hanke","year":"2011","journal-title":"Clin Sci (Lond)."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0360","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/glia.20928","article-title":"Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury","volume":"58","author":"Lehnardt","year":"2010","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0365","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/cvr\/cvu067","article-title":"Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension","volume":"103","author":"Dange","year":"2014","journal-title":"Cardiovasc Res."},{"key":"10.1016\/j.phrs.2019.04.029_bib0370","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12974-015-0242-7","article-title":"Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension","volume":"12","author":"Dange","year":"2015","journal-title":"J Neuroinflammation."},{"key":"10.1016\/j.phrs.2019.04.029_bib0375","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.taap.2016.06.014","article-title":"TLR4\/MyD88\/NF-\u03baB signaling and PPAR-\u03b3 within the paraventricular nucleus are involved in the effects of telmisartan in hypertension","volume":"305","author":"Li","year":"2016","journal-title":"Toxicology and applied pharmacology"},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0380","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1476-9255-9-48","article-title":"Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation","volume":"9","author":"Ahmad","year":"2012","journal-title":"J Inflamm (Lond)."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2019.04.029_bib0385","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12026-014-8548-6","article-title":"The immune system and hypertension","volume":"59","author":"Singh","year":"2014","journal-title":"Immunol Res."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0390","doi-asserted-by":"crossref","first-page":"R274","DOI":"10.1152\/ajpregu.00546.2011","article-title":"Oxidative stress contributes to sex differences in angiotensin II-mediated hypertension in spontaneously hypertensive rats","volume":"302","author":"Bhatia","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0395","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/HYPERTENSIONAHA.109.144840","article-title":"mPGES-1 protects against DOCA-salt hypertension via inhibition of oxidative stress or stimulation of NO\/cGMP","volume":"55","author":"Jia","year":"2010","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0400","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/HYPERTENSIONAHA.111.172718","article-title":"Role of vascular extracellular superoxide dismutase in hypertension","volume":"58","author":"Lob","year":"2011","journal-title":"Hypertension."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib0405","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/hh1701.096037","article-title":"Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice","volume":"89","author":"Rey","year":"2001","journal-title":"Circ Res."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0410","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pharmthera.2010.01.003","article-title":"Effects of tempol and redox-cycling nitroxides in models of oxidative stress","volume":"126","author":"Wilcox","year":"2010","journal-title":"Pharmacol Ther."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0415","doi-asserted-by":"crossref","first-page":"813","DOI":"10.33549\/physiolres.931581","article-title":"Participation of nitric oxide in different models of experimental hypertension","volume":"57","author":"Torok","year":"2008","journal-title":"Physiol Res."},{"key":"10.1016\/j.phrs.2019.04.029_bib0420","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.redox.2016.11.011","article-title":"Increased mitochondrial superoxide in the brain, but not periphery, sensitizes mice to angiotensin II-mediated hypertension","volume":"11","author":"Case","year":"2017","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0425","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.109.214601","article-title":"Therapeutic targeting of mitochondrial superoxide in hypertension","volume":"107","author":"Dikalova","year":"2010","journal-title":"Circ Res."},{"key":"10.1016\/j.phrs.2019.04.029_bib0430","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuint.2017.02.014","article-title":"Selol, an organic selenium donor, prevents lipopolysaccharide-induced oxidative stress and inflammatory reaction in the rat brain","volume":"108","author":"Dominiak","year":"2017","journal-title":"Neurochem Int."},{"issue":"19","key":"10.1016\/j.phrs.2019.04.029_bib0435","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1161\/01.CIR.0000128695.49900.12","article-title":"Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats","volume":"109","author":"Kishi","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0440","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/FJC.0b013e3181ce9681","article-title":"Sympathoinhibition induced by centrally administered atorvastatin is associated with alteration of NAD(P)H and Mn superoxide dismutase activity in rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats","volume":"55","author":"Kishi","year":"2010","journal-title":"J Cardiovasc Pharmacol."},{"key":"10.1016\/j.phrs.2019.04.029_bib0445","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.neulet.2015.12.015","article-title":"Effects of chronic treatment with methylphenidate on oxidative stress and inflammation in hippocampus of adult rats","volume":"619","author":"Motaghinejad","year":"2016","journal-title":"Neurosci Lett."},{"key":"10.1016\/j.phrs.2019.04.029_bib0450","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.freeradbiomed.2014.06.001","article-title":"Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration","volume":"73","author":"Savalia","year":"2014","journal-title":"Free Radic Biol Med."},{"key":"10.1016\/j.phrs.2019.04.029_bib0455","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.toxlet.2015.10.019","article-title":"Alpha lipoic acid supplementation attenuates reactive oxygen species in hypothalamic paraventricular nucleus and sympathoexcitation in high salt-induced hypertension","volume":"241","author":"Su","year":"2016","journal-title":"Toxicol Lett."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0460","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/HYPERTENSIONAHA.113.02057","article-title":"In vivo transfection of manganese superoxide dismutase gene or nuclear factor kappaB shRNA in nodose ganglia improves aortic baroreceptor function in heart failure rats","volume":"63","author":"Zhang","year":"2014","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0465","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/01.RES.0000135483.12297.e4","article-title":"Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system","volume":"95","author":"Zimmerman","year":"2004","journal-title":"Circ Res."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib0470","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1152\/jn.01329.2006","article-title":"Signaling mechanisms of angiotensin II-induced attenuation of GABAergic input to hypothalamic presympathetic neurons","volume":"97","author":"Chen","year":"2007","journal-title":"J Neurophysiol."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0475","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00424-007-0256-9","article-title":"Endogenous hydrogen peroxide in paraventricular nucleus mediating cardiac sympathetic afferent reflex and regulating sympathetic activity","volume":"454","author":"Yu","year":"2007","journal-title":"Pflugers Arch."},{"issue":"9","key":"10.1016\/j.phrs.2019.04.029_bib0480","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1097\/HJH.0b013e32835613d7","article-title":"Different role of oxidative stress in paraventricular nucleus and rostral ventrolateral medulla in cardiovascular regulation in awake spontaneously hypertensive rats","volume":"30","author":"Nishihara","year":"2012","journal-title":"J Hypertens."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0485","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/HJH.0b013e32834e1df4","article-title":"Oxidative stress in the rostral ventrolateral medulla modulates excitatory and inhibitory inputs in spontaneously hypertensive rats","volume":"30","author":"Nishihara","year":"2012","journal-title":"J Hypertens."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0490","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.cardiores.2006.05.020","article-title":"Critical role for p47phox in renin-angiotensin system activation and blood pressure regulation","volume":"71","author":"Grote","year":"2006","journal-title":"Cardiovasc Res."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0495","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/ajh.2010.173","article-title":"High salt intake delayed angiotensin II-induced hypertension in mice with a genetic variant of NADPH oxidase","volume":"24","author":"Haque","year":"2011","journal-title":"Am J Hypertens."},{"key":"10.1016\/j.phrs.2019.04.029_bib0500","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.freeradbiomed.2016.05.012","article-title":"Impaired Nrf2 regulation of mitochondrial biogenesis in rostral ventrolateral medulla on hypertension induced by systemic inflammation","volume":"97","author":"Wu","year":"2016","journal-title":"Free Radic Biol Med."},{"issue":"9","key":"10.1016\/j.phrs.2019.04.029_bib0505","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/CIRCRESAHA.109.199018","article-title":"Transcriptional upregulation of mitochondrial uncoupling protein 2 protects against oxidative stress-associated neurogenic hypertension","volume":"105","author":"Chan","year":"2009","journal-title":"Circ Res."},{"issue":"9","key":"10.1016\/j.phrs.2019.04.029_bib0510","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1161\/CIRCRESAHA.110.225573","article-title":"Transcriptional upregulation of brain-derived neurotrophic factor in rostral ventrolateral medulla by angiotensin II: significance in superoxide homeostasis and neural regulation of arterial pressure","volume":"107","author":"Chan","year":"2010","journal-title":"Circ Res."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0515","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/HYPERTENSIONAHA.108.116905","article-title":"Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension","volume":"53","author":"Chan","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2019.04.029_bib0520","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.redox.2013.11.002","article-title":"Over-expressed copper\/zinc superoxide dismutase localizes to mitochondria in neurons inhibiting the angiotensin II-mediated increase in mitochondrial superoxide","volume":"2","author":"Li","year":"2013","journal-title":"Redox Biol."},{"issue":"11","key":"10.1016\/j.phrs.2019.04.029_bib0525","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1097\/HJH.0b013e32830dd5d3","article-title":"Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla","volume":"26","author":"Nozoe","year":"2008","journal-title":"J Hypertens."},{"key":"10.1016\/j.phrs.2019.04.029_bib0530","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.04.050","article-title":"Mineralocorticoid and angiotensin II type 1 receptors in the subfornical organ mediate angiotensin II - induced hypothalamic reactive oxygen species and hypertension","volume":"329","author":"Wang","year":"2016","journal-title":"Neuroscience"},{"issue":"10","key":"10.1016\/j.phrs.2019.04.029_bib0535","doi-asserted-by":"crossref","first-page":"C803","DOI":"10.1152\/ajpcell.00223.2014","article-title":"Endoplasmic reticulum and oxidant stress mediate nuclear factor-kappaB activation in the subfornical organ during angiotensin II hypertension","volume":"308","author":"Young","year":"2015","journal-title":"Am J Physiol Cell Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0540","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1161\/HYPERTENSIONAHA.109.142646","article-title":"Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system","volume":"55","author":"Lob","year":"2010","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.phrs.2019.04.029_bib0545","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1089\/ars.2012.4585","article-title":"Angiotensin-generated reactive oxygen species in brain and pathogenesis of cardiovascular diseases","volume":"19","author":"Chan","year":"2013","journal-title":"Antioxid Redox Signal."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0550","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/HYPERTENSIONAHA.109.149146","article-title":"Oral intake of rosiglitazone promotes a central antihypertensive effect via upregulation of peroxisome proliferator-activated receptor-gamma and alleviation of oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats","volume":"55","author":"Chan","year":"2010","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0555","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neurobiolaging.2013.08.015","article-title":"Uncoupling protein 2 deficiency aggravates astrocytic endoplasmic reticulum stress and nod-like receptor protein 3 inflammasome activation","volume":"35","author":"Lu","year":"2014","journal-title":"Neurobiol Aging."},{"issue":"9","key":"10.1016\/j.phrs.2019.04.029_bib0560","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/0002-9149(94)90583-5","article-title":"Alterations in nitric oxide synthase activity, superoxide anion generation, and platelet aggregation in systemic hypertension, and effects of celiprolol","volume":"74","author":"Mehta","year":"1994","journal-title":"Am J Cardiol."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0565","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/01.HYP.17.3.323","article-title":"Leukocyte counts and activation in spontaneously hypertensive and normotensive rats","volume":"17","author":"Schmid-Schonbein","year":"1991","journal-title":"Hypertension"},{"issue":"7-8","key":"10.1016\/j.phrs.2019.04.029_bib0570","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1139\/o95-054","article-title":"Properties of circulating leukocytes in spontaneously hypertensive rats","volume":"73","author":"Shen","year":"1995","journal-title":"Biochem Cell Biol."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0575","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00004872-200018060-00007","article-title":"Polymorphonuclear leukocytes (PMNs) functions in SHR, L-NAME- and DOCA\/salt-induced hypertensive rats","volume":"18","author":"Ohmori","year":"2000","journal-title":"J Hypertens."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0580","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1152\/physrev.00039.2016","article-title":"Neuroimmune Interactions: From the Brain to the Immune System and Vice Versa","volume":"98","author":"Dantzer","year":"2018","journal-title":"Physiol Rev."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0585","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0031-6997(24)01470-4","article-title":"The sympathetic nerve\u2014an integrative interface between two supersystems: the brain and the immune system","volume":"52","author":"Elenkov","year":"2000","journal-title":"Pharmacol Rev."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0590","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood-brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0595","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCRESAHA.110.217299","article-title":"Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension","volume":"107","author":"Marvar","year":"2010","journal-title":"Circ Res."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0600","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/HYPERTENSIONAHA.114.03581","article-title":"Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension","volume":"64","author":"Pollow","year":"2014","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0605","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/CIRCRESAHA.117.305853","article-title":"Involvement of bone marrow cells and neuroinflammation in hypertension","volume":"117","author":"Santisteban","year":"2015","journal-title":"Circ Res."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib0610","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/HYPERTENSIONAHA.114.05112","article-title":"Proinflammatory cytokines upregulate sympathoexcitatory mechanisms in the subfornical organ of the rat","volume":"65","author":"Wei","year":"2015","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib0615","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/HYPERTENSIONAHA.112.199547","article-title":"Brain-mediated dysregulation of the bone marrow activity in angiotensin II-induced hypertension","volume":"60","author":"Jun","year":"2012","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0620","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/HYPERTENSIONAHA.113.02722","article-title":"Altered inflammatory response is associated with an impaired autonomic input to the bone marrow in the spontaneously hypertensive rat","volume":"63","author":"Zubcevic","year":"2014","journal-title":"Hypertension"},{"issue":"7146","key":"10.1016\/j.phrs.2019.04.029_bib0625","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","article-title":"Resolvin E1 and protectin D1 activate inflammation-resolution programmes","volume":"447","author":"Schwab","year":"2007","journal-title":"Nature."},{"issue":"7503","key":"10.1016\/j.phrs.2019.04.029_bib0630","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0635","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.smim.2015.03.004","article-title":"The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution","volume":"27","author":"Serhan","year":"2015","journal-title":"Semin Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0640","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.ajpath.2017.01.018","article-title":"Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy","volume":"187","author":"Fredman","year":"2017","journal-title":"Am J Pathol."},{"issue":"7","key":"10.1016\/j.phrs.2019.04.029_bib0645","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat Immunol."},{"issue":"8","key":"10.1016\/j.phrs.2019.04.029_bib0650","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1084\/jem.192.8.1197","article-title":"Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing","volume":"192","author":"Serhan","year":"2000","journal-title":"J Exp Med."},{"issue":"8","key":"10.1016\/j.phrs.2019.04.029_bib0655","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J Exp Med."},{"issue":"11","key":"10.1016\/j.phrs.2019.04.029_bib0660","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/nm786","article-title":"Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor","volume":"8","author":"Perretti","year":"2002","journal-title":"Nat Med."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0665","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.smim.2015.05.004","article-title":"Gaseous mediators in resolution of inflammation","volume":"27","author":"Wallace","year":"2015","journal-title":"Semin Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0670","doi-asserted-by":"crossref","first-page":"655","DOI":"10.5551\/jat.33928","article-title":"Novel Endogenous Proresolving Molecules: Essential Fatty Acid-Derived and Gaseous Mediators in the Resolution of Inflammation","volume":"23","author":"Shinohara","year":"2016","journal-title":"J Atheroscler Thromb."},{"issue":"11","key":"10.1016\/j.phrs.2019.04.029_bib0675","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1073\/pnas.96.11.6377","article-title":"Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB","volume":"96","author":"Cronstein","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5663","key":"10.1016\/j.phrs.2019.04.029_bib0680","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"issue":"7559","key":"10.1016\/j.phrs.2019.04.029_bib0685","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature14452","article-title":"Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation","volume":"523","author":"Gagliani","year":"2015","journal-title":"Nature."},{"key":"10.1016\/j.phrs.2019.04.029_bib0690","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plefa.2016.09.003","article-title":"Modulation of brain PUFA content in different experimental models of mice","volume":"114","author":"Joffre","year":"2016","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"30","key":"10.1016\/j.phrs.2019.04.029_bib0695","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1073\/pnas.0402342101","article-title":"Effects of dietary omega-3 polyunsaturated fatty acids on brain gene expression","volume":"101","author":"Kitajka","year":"2004","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0700","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nri3362","article-title":"The resolution of inflammation","volume":"13","author":"Buckley","year":"2013","journal-title":"Nat Rev Immunol."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0705","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbalip.2014.08.010","article-title":"Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance","volume":"1851","author":"Calder","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0710","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrn3876","article-title":"Endocannabinoid signalling and the deteriorating brain","volume":"16","author":"Di Marzo","year":"2015","journal-title":"Nat Rev Neurosci."},{"issue":"9-10","key":"10.1016\/j.phrs.2019.04.029_bib0715","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1023\/A:1007627725251","article-title":"Neuroinflammatory signaling upregulation in Alzheimer\u2019s disease","volume":"25","author":"Lukiw","year":"2000","journal-title":"Neurochem Res."},{"key":"10.1016\/j.phrs.2019.04.029_bib0720","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2015.08.051","article-title":"Fatty acids, endocannabinoids and inflammation","volume":"785","author":"Witkamp","year":"2016","journal-title":"Eur J Pharmacol."},{"issue":"12","key":"10.1016\/j.phrs.2019.04.029_bib0725","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat Rev Neurosci."},{"key":"10.1016\/j.phrs.2019.04.029_bib0730","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","article-title":"Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways","volume":"25","author":"Serhan","year":"2007","journal-title":"Annu Rev Immunol."},{"issue":"3-4","key":"10.1016\/j.phrs.2019.04.029_bib0735","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.plefa.2005.05.002","article-title":"Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution","volume":"73","author":"Serhan","year":"2005","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0740","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1096\/fj.201701498RR","article-title":"Effects of high- and low-dose aspirin on adaptive immunity and hypertension in the stroke-prone spontaneously hypertensive rat","volume":"33","author":"Khan","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2019.04.029_bib0745","doi-asserted-by":"crossref","first-page":"j1909","DOI":"10.1136\/bmj.j1909","article-title":"Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data","volume":"357","author":"Bally","year":"2017","journal-title":"BMJ"},{"issue":"14","key":"10.1016\/j.phrs.2019.04.029_bib0750","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2174\/1381612053764922","article-title":"Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors","volume":"11","author":"Cheng","year":"2005","journal-title":"Curr Pharm Des."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0755","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tips.2009.11.007","article-title":"Dual COXIB\/TP antagonists: a possible new twist in NSAID pharmacology and cardiovascular risk","volume":"31","author":"Rovati","year":"2010","journal-title":"Trends Pharmacol Sci."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0760","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1172\/JCI0214752","article-title":"Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II","volume":"110","author":"Qi","year":"2002","journal-title":"J Clin Invest."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0765","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/9550","article-title":"Inducible cyclooxygenase may have anti-inflammatory properties","volume":"5","author":"Gilroy","year":"1999","journal-title":"Nat Med."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0770","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1021\/jm501051x","article-title":"FPR2\/ALXR agonists and the resolution of inflammation","volume":"58","author":"Corminboeuf","year":"2015","journal-title":"J Med Chem."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0775","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/10641969609082605","article-title":"Effects of MaxEPA on salt-induced hypertension: relationship to [3H]nitrobenzylthioinosine binding sites","volume":"18","author":"Bayorh","year":"1996","journal-title":"Clin Exp Hypertens."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0780","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11745-002-0933-z","article-title":"Antihypertensive effects of a dietary unsaturated FA mixture in spontaneously hypertensive rats","volume":"37","author":"Bellenger-Germain","year":"2002","journal-title":"Lipids."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib0785","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jn\/119.5.813","article-title":"Effects of dietary fish oil or pectin on blood pressure and lipid metabolism in the DOCA-salt hypertensive rat","volume":"119","author":"Bond","year":"1989","journal-title":"J Nutr."},{"issue":"8","key":"10.1016\/j.phrs.2019.04.029_bib0790","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/ajh\/2.8.610","article-title":"Antihypertensive properties of linoleic acid and fish oil omega-3 fatty acids independent of the prostaglandin system","volume":"2","author":"Hui","year":"1989","journal-title":"Am J Hypertens."},{"issue":"8 Suppl. 1","key":"10.1016\/j.phrs.2019.04.029_bib0795","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.2459\/01.JCM.0000289279.95427.e2","article-title":"Fish, n-3 fatty acids, and cardiovascular haemodynamics","author":"Mozaffarian","year":"2007","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"10.1016\/j.phrs.2019.04.029_bib0800","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0163-7827(81)90102-8","article-title":"Effect of a diet containing fish oil on blood pressure in spontaneously hypertensive rats","volume":"20","author":"Schoene","year":"1981","journal-title":"Prog Lipid Res."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0805","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1476-5381.1991.tb12289.x","article-title":"Blood pressure and vascular reactivity changes in spontaneously hypertensive rats fed fish oil","volume":"102","author":"Yin","year":"1991","journal-title":"Br J Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0810","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1440-1681.1990.tb01313.x","article-title":"Effect of fish oil feeding on blood pressure and vascular reactivity in spontaneously hypertensive rats","volume":"17","author":"Yin","year":"1990","journal-title":"Clin Exp Pharmacol Physiol."},{"issue":"5-6","key":"10.1016\/j.phrs.2019.04.029_bib0815","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.plefa.2009.03.003","article-title":"Docosahexaenoic acid, but not eicosapentaenoic acid, lowers ambulatory blood pressure and shortens interval QT in spontaneously hypertensive rats in vivo","volume":"80","author":"Rousseau-Ralliard","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib0820","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1097\/HJH.0000000000000131","article-title":"Dietary fish oil improves endothelial function and lowers blood pressure via suppression of sphingolipid-mediated contractions in spontaneously hypertensive rats","volume":"32","author":"van den Elsen","year":"2014","journal-title":"J Hypertens."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0825","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3892\/ijmm.2016.2846","article-title":"Inhibitory effects of alpha-lipoic acid on oxidative stress in the rostral ventrolateral medulla in rats with salt-induced hypertension","volume":"39","author":"Huang","year":"2017","journal-title":"Int J Mol Med."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0830","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/08037059509077591","article-title":"Fish oils modulate blood pressure and vascular contractility in the rat and vascular contractility in the primate","volume":"4","author":"Mano","year":"1995","journal-title":"Blood Press."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0835","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11745-003-1084-y","article-title":"Increased blood pressure later in life may be associated with perinatal n-3 fatty acid deficiency","volume":"38","author":"Armitage","year":"2003","journal-title":"Lipids."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0840","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/85354","article-title":"Perinatal omega-3 fatty acid deficiency affects blood pressure later in life","volume":"7","author":"Weisinger","year":"2001","journal-title":"Nat Med."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib0845","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/01.HYP.25.5.1014","article-title":"Angiotensin and bradykinin peptides in the TGR(mRen-2)27 rat","volume":"25","author":"Campbell","year":"1995","journal-title":"Hypertension"},{"issue":"3 Pt 2","key":"10.1016\/j.phrs.2019.04.029_bib0850","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/01.HYP.27.3.573","article-title":"Salt-sensitive hypertension in (mREN-2)27 transgenic rats","volume":"27","author":"Callahan","year":"1996","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0855","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/hr.2011.194","article-title":"Hypothalamic gene expression in omega-3 PUFA-deficient male rats before, and following, development of hypertension","volume":"35","author":"Begg","year":"2012","journal-title":"Hypertens Res."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0860","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.plefa.2007.11.001","article-title":"Omega-3 polyunsaturated fatty acid supplementation reduces hypertension in TGR(mRen-2)27 rats","volume":"78","author":"Jayasooriya","year":"2008","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0865","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1111\/jpn.12804","article-title":"Polyunsaturated fatty acids influence inflammatory markers in a cellular model for canine osteoarthritis","volume":"102","author":"Adler","year":"2018","journal-title":"J Anim Physiol Anim Nutr (Berl)."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0870","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.clnu.2012.09.009","article-title":"Rapid EPA and DHA incorporation and reduced PGE2 levels after one week intervention with a medical food in cancer patients receiving radiotherapy, a randomized trial","volume":"32","author":"Faber","year":"2013","journal-title":"Clin Nutr."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib0875","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1017\/S0007114511003503","article-title":"Effects of dietary n-3 and n-6 fatty acids on clinical outcome in a porcine model on post-operative infection","volume":"107","author":"Langerhuus","year":"2012","journal-title":"Br J Nutr."},{"issue":"9","key":"10.1016\/j.phrs.2019.04.029_bib0880","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s11745-013-3816-0","article-title":"Fish oil decreases C-reactive protein\/albumin ratio improving nutritional prognosis and plasma fatty acid profile in colorectal cancer patients","volume":"48","author":"Mocellin","year":"2013","journal-title":"Lipids"},{"key":"10.1016\/j.phrs.2019.04.029_bib0885","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/709493","article-title":"Efficacy of fish oil on serum of TNF alpha, IL-1 beta, and IL-6 oxidative stress markers in multiple sclerosis treated with interferon beta-1b","volume":"2013","author":"Ramirez-Ramirez","year":"2013","journal-title":"Oxid Med Cell Longev."},{"issue":"12","key":"10.1016\/j.phrs.2019.04.029_bib0890","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.jnutbio.2011.11.009","article-title":"n-3 and n-6 polyunsaturated fatty acids differentially regulate adipose angiotensinogen and other inflammatory adipokines in part via NF-kappaB-dependent mechanisms","volume":"23","author":"Siriwardhana","year":"2012","journal-title":"J Nutr Biochem."},{"issue":"1-3","key":"10.1016\/j.phrs.2019.04.029_bib0895","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejphar.2011.07.043","article-title":"Eicosapentaenoic acid regulates IkappaBalpha and prevents tubulointerstitial injury in kidney","volume":"669","author":"Takase","year":"2011","journal-title":"Eur J Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0900","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3181\/00379727-214-44106","article-title":"Effect of cis-unsaturated fatty acids, prostaglandins, and free radicals on angiotensin-converting enzyme activity in vitro","volume":"214","author":"Kumar","year":"1997","journal-title":"Proc Soc Exp Biol Med."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0905","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2174\/157016109788340659","article-title":"Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management","volume":"7","author":"Cicero","year":"2009","journal-title":"Curr Vasc Pharmacol."},{"issue":"1 Suppl","key":"10.1016\/j.phrs.2019.04.029_bib0910","doi-asserted-by":"crossref","first-page":"213S","DOI":"10.1093\/ajcn\/71.1.213S","article-title":"Fatty acid modulation of endothelial activation","volume":"71","author":"De Caterina","year":"2000","journal-title":"Am J Clin Nutr."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0915","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/BF00504869","article-title":"Vasoconstriction induced by noradrenaline and angiotensin II is antagonized by eicosapentaenoic acid independent of formation of trienoic eicosanoids","volume":"332","author":"Juan","year":"1986","journal-title":"Naunyn Schmiedebergs Arch Pharmacol."},{"key":"10.1016\/j.phrs.2019.04.029_bib0920","first-page":"57","article-title":"Influence of eicosapentaenoic acid on noradrenaline and angiotensin-induced contractions of the rabbit aorta: mode of action","volume":"242","author":"Juan","year":"1987","journal-title":"Prog Clin Biol Res."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0925","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.phrs.2007.04.004","article-title":"Angiotensin-(1-7) blocks the angiotensin II-stimulated superoxide production","volume":"56","author":"Polizio","year":"2007","journal-title":"Pharmacol Res."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0930","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1160\/TH06-06-0315","article-title":"Aspirin-triggered lipoxin A4 blocks reactive oxygen species generation in endothelial cells: a novel antioxidative mechanism","volume":"97","author":"Nascimento-Silva","year":"2007","journal-title":"Thromb Haemost."},{"issue":"1 Pt 2","key":"10.1016\/j.phrs.2019.04.029_bib0935","first-page":"R217","article-title":"Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles","volume":"270","author":"Imig","year":"1996","journal-title":"Am J Physiol."},{"issue":"10","key":"10.1016\/j.phrs.2019.04.029_bib0940","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1182\/blood.V95.10.3106","article-title":"In vitro differentiation of endothelial cells from AC133-positive progenitor cells","volume":"95","author":"Gehling","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib0945","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1046\/j.1523-1755.2000.057003863.x","article-title":"Understanding hypertension through genetic manipulation in mice","volume":"57","author":"Cvetkovic","year":"2000","journal-title":"Kidney Int."},{"issue":"8","key":"10.1016\/j.phrs.2019.04.029_bib0950","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/ATVBAHA.112.248344","article-title":"Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction","volume":"32","author":"Cheng","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"4889","key":"10.1016\/j.phrs.2019.04.029_bib0955","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.2492116","article-title":"Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats","volume":"243","author":"Sacerdoti","year":"1989","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0960","doi-asserted-by":"crossref","first-page":"H2455","DOI":"10.1152\/ajpheart.00512.2008","article-title":"Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats","volume":"295","author":"Dunn","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib0965","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1152\/ajpregu.00039.2015","article-title":"Angiotensin II receptor blockade or deletion of vascular endothelial ACE does not prevent vascular dysfunction and remodeling in 20-HETE-dependent hypertension","volume":"309","author":"Garcia","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0970","doi-asserted-by":"crossref","first-page":"C1420","DOI":"10.1152\/ajpcell.00380.2008","article-title":"Lipoxin A4 inhibits IL-1beta-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells","volume":"296","author":"Decker","year":"2009","journal-title":"Am J Physiol Cell Physiol."},{"key":"10.1016\/j.phrs.2019.04.029_bib0975","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1038\/srep07458","article-title":"n-3 PUFA supplementation benefits microglial responses to myelin pathology","volume":"4","author":"Chen","year":"2014","journal-title":"Sci Rep."},{"key":"10.1016\/j.phrs.2019.04.029_bib0980","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbi.2013.02.005","article-title":"Characterization of phenotype markers and neuronotoxic potential of polarised primary microglia in vitro","volume":"32","author":"Chhor","year":"2013","journal-title":"Brain Behav Immun."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib0985","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/j.1471-4159.2009.06286.x","article-title":"Docosahexaenoic acid attenuates microglial activation and delays early retinal degeneration","volume":"110","author":"Ebert","year":"2009","journal-title":"J Neurochem."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib0990","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3233\/JAD-130131","article-title":"Omega-3 fatty acids enhance phagocytosis of Alzheimer\u2019s disease-related amyloid-beta42 by human microglia and decrease inflammatory markers","volume":"35","author":"Hjorth","year":"2013","journal-title":"J Alzheimers Dis."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib0995","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.intimp.2006.10.001","article-title":"Inhibitory effects of eicosapentaenoic acid on lipopolysaccharide-induced activation in BV2 microglia","volume":"7","author":"Moon","year":"2007","journal-title":"Int Immunopharmacol."},{"key":"10.1016\/j.phrs.2019.04.029_bib1000","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2015.05.045","article-title":"N-3 polyunsaturated fatty acids in animal models with neuroinflammation: An update","volume":"785","author":"Trepanier","year":"2016","journal-title":"Eur J Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib1005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jnr.22783","article-title":"Docosahexaenoic acid modulates inflammatory and antineurogenic functions of activated microglial cells","volume":"90","author":"Antonietta Ajmone-Cat","year":"2012","journal-title":"J Neurosci Res."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib1010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/09637486.2014.986073","article-title":"Supplementation of omega 3 fatty acids improves oxidative stress in activated BV2 microglial cell line","volume":"66","author":"Corsi","year":"2015","journal-title":"Int J Food Sci Nutr."},{"issue":"11","key":"10.1016\/j.phrs.2019.04.029_bib1015","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1038\/npp.2010.98","article-title":"Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for omega-3 fatty acids","volume":"35","author":"Lu","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2019.04.029_bib1020","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1476-511X-12-16","article-title":"Modulating the inflammatory properties of activated microglia with Docosahexaenoic acid and Aspirin","volume":"12","author":"Pettit","year":"2013","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.phrs.2019.04.029_bib1025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jneuroim.2014.11.007","article-title":"Omega-3 polyunsaturated fatty acids ameliorate neuroinflammation and mitigate ischemic stroke damage through interactions with astrocytes and microglia","volume":"278","author":"Zendedel","year":"2015","journal-title":"J Neuroimmunol."},{"issue":"12","key":"10.1016\/j.phrs.2019.04.029_bib1030","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1007\/s11064-007-9415-9","article-title":"Inhibitory effect of polyunsaturated fatty acids on MMP-9 release from microglial cells\u2014implications for complementary multiple sclerosis treatment","volume":"32","author":"Liuzzi","year":"2007","journal-title":"Neurochem Res."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib1035","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1471-4159.2007.05129.x","article-title":"Docosahexaenoic acid prevents lipopolysaccharide-induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization","volume":"105","author":"De Smedt-Peyrusse","year":"2008","journal-title":"J Neurochem."},{"key":"10.1016\/j.phrs.2019.04.029_bib1040","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12974-015-0244-5","article-title":"Docosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphology","volume":"12","author":"Chang","year":"2015","journal-title":"J Neuroinflammation."},{"issue":"28","key":"10.1016\/j.phrs.2019.04.029_bib1045","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","article-title":"Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin","volume":"29","author":"Ma","year":"2009","journal-title":"J Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib1050","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12031-011-9620-5","article-title":"A lipoxin A4 analog ameliorates blood-brain barrier dysfunction and reduces MMP-9 expression in a rat model of focal cerebral ischemia-reperfusion injury","volume":"46","author":"Wu","year":"2012","journal-title":"J Mol Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib1055","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3892\/etm.2015.2363","article-title":"Neuroprotective effect of interleukin-6 in a rat model of cerebral ischemia","volume":"9","author":"Feng","year":"2015","journal-title":"Exp Ther Med."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib1060","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.688","article-title":"Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: Protective mechanisms and long-term effects on neurological recovery","volume":"7","author":"Hawkins","year":"2017","journal-title":"Brain Behav."},{"issue":"1 supplement","key":"10.1016\/j.phrs.2019.04.029_bib1065","article-title":"Angiotensin II-Mediated AT1R-TLR4 Crosstalk Promotes Blood-Brain Barrier Disruption, Microglial Activation, and Sympathoexcitation in Hypertension","volume":"33","author":"Mowry","year":"2019","journal-title":"The FASEB Journal."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib1070","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1073\/pnas.0907342107","article-title":"Resolvin D1 binds human phagocytes with evidence for proresolving receptors","volume":"107","author":"Krishnamoorthy","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib1075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.20042031","article-title":"Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1","volume":"201","author":"Arita","year":"2005","journal-title":"J Exp Med."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib1080","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/(SICI)1521-4141(199805)28:05<1689::AID-IMMU1689>3.0.CO;2-I","article-title":"ChemR23, a putative chemoattractant receptor, is expressed in monocyte-derived dendritic cells and macrophages and is a coreceptor for SIV and some primary HIV-1 strains","volume":"28","author":"Samson","year":"1998","journal-title":"Eur J Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib1085","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s11481-012-9394-8","article-title":"Resolvin E1 inhibits neuropathic pain and spinal cord microglial activation following peripheral nerve injury","volume":"8","author":"Xu","year":"2013","journal-title":"J Neuroimmune Pharmacol."},{"key":"10.1016\/j.phrs.2019.04.029_bib1090","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbi.2015.01.001","article-title":"Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse","volume":"47","author":"Harrison","year":"2015","journal-title":"Brain Behav Immun."},{"key":"10.1016\/j.phrs.2019.04.029_bib1095","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bbi.2015.12.013","article-title":"Resolvin D1 and E1 promote resolution of inflammation in microglial cells in vitro","volume":"55","author":"Rey","year":"2016","journal-title":"Brain Behav Immun."},{"issue":"17","key":"10.1016\/j.phrs.2019.04.029_bib1100","doi-asserted-by":"crossref","first-page":"14677","DOI":"10.1074\/jbc.M300218200","article-title":"Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation","volume":"278","author":"Hong","year":"2003","journal-title":"J Biol Chem."},{"issue":"10","key":"10.1016\/j.phrs.2019.04.029_bib1105","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1172\/JCI25420","article-title":"A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease","volume":"115","author":"Lukiw","year":"2005","journal-title":"J Clin Invest."},{"issue":"44","key":"10.1016\/j.phrs.2019.04.029_bib1110","doi-asserted-by":"crossref","first-page":"43807","DOI":"10.1074\/jbc.M305841200","article-title":"Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression","volume":"278","author":"Marcheselli","year":"2003","journal-title":"J Biol Chem."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib1115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.plefa.2009.10.010","article-title":"Neuroprotectin D1\/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils","volume":"82","author":"Marcheselli","year":"2010","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib1120","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/jnc.12392","article-title":"Unesterified docosahexaenoic acid is protective in neuroinflammation","volume":"127","author":"Orr","year":"2013","journal-title":"J Neurochem."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib1125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.plefa.2012.05.008","article-title":"n-3 Polyunsaturated fatty acids in animal models with neuroinflammation","volume":"88","author":"Orr","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib1130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12974-016-0751-z","article-title":"N-Docosahexaenoylethanolamine ameliorates LPS-induced neuroinflammation via cAMP\/PKA-dependent signaling","volume":"13","author":"Park","year":"2016","journal-title":"J Neuroinflammation."},{"issue":"12","key":"10.1016\/j.phrs.2019.04.029_bib1135","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1017\/S0007114510005635","article-title":"The ethanolamide metabolite of DHA, docosahexaenoylethanolamine, shows immunomodulating effects in mouse peritoneal and RAW264.7 macrophages: evidence for a new link between fish oil and inflammation","volume":"105","author":"Meijerink","year":"2011","journal-title":"Br J Nutr."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib1140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/bph.12747","article-title":"Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages","volume":"172","author":"Meijerink","year":"2015","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.phrs.2019.04.029_bib1145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.biochi.2017.01.002","article-title":"Bioactive metabolites of docosahexaenoic acid","volume":"136","author":"Kuda","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.phrs.2019.04.029_bib1150","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fimmu.2012.00081","article-title":"Functional Metabolomics Reveals Novel Active Products in the DHA Metabolome","volume":"3","author":"Shinohara","year":"2012","journal-title":"Front Immunol."},{"issue":"36","key":"10.1016\/j.phrs.2019.04.029_bib1155","doi-asserted-by":"crossref","first-page":"31532","DOI":"10.1074\/jbc.M111.237990","article-title":"Decoding functional metabolomics with docosahexaenoyl ethanolamide (DHEA) identifies novel bioactive signals","volume":"286","author":"Yang","year":"2011","journal-title":"J Biol Chem."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib1160","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nn.3612","article-title":"Peripheral gating of pain signals by endogenous lipid mediators","volume":"17","author":"Piomelli","year":"2014","journal-title":"Nat Neurosci."},{"issue":"56 Suppl 1","key":"10.1016\/j.phrs.2019.04.029_bib1165","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2008.07.037","article-title":"Endocannabinoid signaling in microglial cells","author":"Stella","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2019.04.029_bib1170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2011.07.046","article-title":"Role of brainstem GABAergic signaling in central cannabinoid receptor evoked sympathoexcitation and pressor responses in conscious rats","volume":"1414","author":"Ibrahim","year":"2011","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib1175","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.brainres.2005.08.030","article-title":"Uptake blockade of endocannabinoids in the NTS modulates baroreflex-evoked sympathoinhibition","volume":"1059","author":"Brozoski","year":"2005","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib1180","doi-asserted-by":"crossref","first-page":"H992","DOI":"10.1152\/ajpheart.00870.2003","article-title":"Anandamide content and interaction of endocannabinoid\/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition","volume":"286","author":"Seagard","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"8","key":"10.1016\/j.phrs.2019.04.029_bib1185","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.12108","article-title":"Acute and chronic systemic CB1 cannabinoid receptor blockade improves blood pressure regulation and metabolic profile in hypertensive (mRen2)27 rats","volume":"2","author":"Schaich","year":"2014","journal-title":"Physiol Rep."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib1190","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/HJH.0000000000001179","article-title":"Overactivation of cannabinoid receptor type 1 in rostral ventrolateral medulla promotes cardiovascular responses in spontaneously hypertensive rats","volume":"35","author":"Wang","year":"2017","journal-title":"J Hypertens."},{"issue":"23","key":"10.1016\/j.phrs.2019.04.029_bib1195","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.2174\/138161208785740045","article-title":"Endocannabinoid signaling and neuroinflammatory diseases","volume":"14","author":"Maccarrone","year":"2008","journal-title":"Curr Pharm Des."},{"issue":"10","key":"10.1016\/j.phrs.2019.04.029_bib1200","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.tem.2015.07.007","article-title":"The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease","volume":"26","author":"Mazier","year":"2015","journal-title":"Trends Endocrinol Metab."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib1205","doi-asserted-by":"crossref","first-page":"334","DOI":"10.2174\/1389450115666141202113225","article-title":"The activated endocannabinoid system in atherosclerosis: driving force or protective mechanism?","volume":"16","author":"Steffens","year":"2015","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.phrs.2019.04.029_bib1210","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/978-3-319-20825-1_16","article-title":"Endocannabinoids and Cancer","volume":"231","author":"Velasco","year":"2015","journal-title":"Handb Exp Pharmacol."},{"issue":"18","key":"10.1016\/j.phrs.2019.04.029_bib1215","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1089\/neu.2016.4808","article-title":"N-Palmitoylethanolamine-Oxazoline as a New Therapeutic Strategy to Control Neuroinflammation: Neuroprotective Effects in Experimental Models of Spinal Cord and Brain Injury","volume":"34","author":"Impellizzeri","year":"2017","journal-title":"J Neurotrauma."},{"key":"10.1016\/j.phrs.2019.04.029_bib1220","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.01.007","article-title":"N-Palmitoylethanolamine-oxazoline (PEA-OXA): A new therapeutic strategy to reduce neuroinflammation, oxidative stress associated to vascular dementia in an experimental model of repeated bilateral common carotid arteries occlusion","author":"Impellizzeri","year":"2019","journal-title":"Neurobiol Dis."},{"key":"10.1016\/j.phrs.2019.04.029_bib1225","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pharmthera.2016.06.011","article-title":"Microglia activation states and cannabinoid system: Therapeutic implications","volume":"166","author":"Mecha","year":"2016","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.phrs.2019.04.029_bib1230","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbi.2015.06.002","article-title":"Endocannabinoids drive the acquisition of an alternative phenotype in microglia","volume":"49","author":"Mecha","year":"2015","journal-title":"Brain Behav Immun."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib1235","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s12035-015-9253-8","article-title":"N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution","volume":"52","author":"Skaper","year":"2015","journal-title":"Mol Neurobiol."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib1240","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drudis.2016.08.005","article-title":"Targeting the endocannabinoid system: future therapeutic strategies","volume":"22","author":"Aizpurua-Olaizola","year":"2017","journal-title":"Drug Discov Today."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib1245","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ana.23875","article-title":"Distinct modulation of human myeloid and plasmacytoid dendritic cells by anandamide in multiple sclerosis","volume":"73","author":"Chiurchiu","year":"2013","journal-title":"Ann Neurol."},{"issue":"1","key":"10.1016\/j.phrs.2019.04.029_bib1250","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2013.12.042","article-title":"Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor","volume":"233","author":"Chiurchiu","year":"2014","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib1255","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.150276","article-title":"Modulation of cellular redox homeostasis by the endocannabinoid system","volume":"6","author":"Lipina","year":"2016","journal-title":"Open Biol."},{"key":"10.1016\/j.phrs.2019.04.029_bib1260","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/978-3-319-20825-1_6","article-title":"Endocannabinoids and the Immune System in Health and Disease","volume":"231","author":"Cabral","year":"2015","journal-title":"Handb Exp Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib1265","doi-asserted-by":"crossref","first-page":"H801","DOI":"10.1152\/ajpheart.00908.2011","article-title":"Angiotensin-(1-7) attenuates angiotensin II-induced cardiac remodeling associated with upregulation of dual-specificity phosphatase 1","volume":"302","author":"McCollum","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib1270","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.113.01274","article-title":"Angiotensin-(1-7)","volume":"63","author":"Santos","year":"2014","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.phrs.2019.04.029_bib1275","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/CIRCRESAHA.113.301077","article-title":"Discovery and characterization of alamandine: a novel component of the renin-angiotensin system","volume":"112","author":"Lautner","year":"2013","journal-title":"Circ Res."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib1280","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/CIRCRESAHA.107.169110","article-title":"Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation","volume":"102","author":"Feng","year":"2008","journal-title":"Circ Res."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib1285","doi-asserted-by":"crossref","first-page":"R370","DOI":"10.1152\/ajpregu.00366.2014","article-title":"Brain ACE2 overexpression reduces DOCA-salt hypertension independently of endoplasmic reticulum stress","volume":"308","author":"Xia","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib1290","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/01.HYP.0000259942.38108.20","article-title":"Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats","volume":"49","author":"Yamazato","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib1295","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib1300","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1161\/HYPERTENSIONAHA.108.123844","article-title":"Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice","volume":"53","author":"Xia","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2019.04.029_bib1305","article-title":"Blockade of Endogenous Angiotensin-(1-7) in Hypothalamic Paraventricular Nucleus Attenuates High Salt-Induced Sympathoexcitation and Hypertension","author":"Yu","year":"2018","journal-title":"Neurosci Bull."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib1310","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00424-010-0793-5","article-title":"Angiotensin-(1-7) and angiotension II in the rostral ventrolateral medulla modulate the cardiac sympathetic afferent reflex and sympathetic activity in rats","volume":"459","author":"Zhou","year":"2010","journal-title":"Pflugers Arch."},{"issue":"9","key":"10.1016\/j.phrs.2019.04.029_bib1315","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","article-title":"Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis","volume":"185","author":"da Silveira","year":"2010","journal-title":"J Immunol."},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib1320","doi-asserted-by":"crossref","first-page":"L1141","DOI":"10.1152\/ajplung.00029.2016","article-title":"Chronic allergic pulmonary inflammation is aggravated in angiotensin-(1-7) Mas receptor knockout mice","volume":"311","author":"Magalhaes","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"issue":"2","key":"10.1016\/j.phrs.2019.04.029_bib1325","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.111.00919","article-title":"Oral formulation of angiotensin-(1-7) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice","volume":"62","author":"Feltenberger","year":"2013","journal-title":"Hypertension."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib1330","doi-asserted-by":"crossref","first-page":"e0150861","DOI":"10.1371\/journal.pone.0150861","article-title":"Anti-Inflammatory Action of Angiotensin 1-7 in Experimental Colitis","volume":"11","author":"Khajah","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib1335","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/ars.2013.5818","article-title":"The angiotensin-converting enzyme 2\/angiotensin (1-7)\/Mas axis protects against lung fibroblast migration and lung fibrosis by inhibiting the NOX4-derived ROS-mediated RhoA\/Rho kinase pathway","volume":"22","author":"Meng","year":"2015","journal-title":"Antioxid Redox Signal."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib1340","doi-asserted-by":"crossref","DOI":"10.1177\/1470320316659618","article-title":"Imbalance between angiotensin II and angiotensin-(1-7) in human coronary atherosclerosis","volume":"17","author":"Li","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.phrs.2019.04.029_bib1345","doi-asserted-by":"crossref","first-page":"27911","DOI":"10.1038\/srep27911","article-title":"Angiotensin-converting enzyme 2 prevents lipopolysaccharide-induced rat acute lung injury via suppressing the ERK1\/2 and NF-kappaB signaling pathways","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep."},{"issue":"9","key":"10.1016\/j.phrs.2019.04.029_bib1350","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/bph.13057","article-title":"Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation","volume":"172","author":"Magalhaes","year":"2015","journal-title":"Br J Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib1355","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bph.12318","article-title":"AVE 0991, a non-peptide mimic of angiotensin-(1-7) effects, attenuates pulmonary remodelling in a model of chronic asthma","volume":"170","author":"Rodrigues-Machado","year":"2013","journal-title":"Br J Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2019.04.029_bib1360","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1164\/rccm.200912-1840OC","article-title":"The angiotensin-converting enzyme 2\/angiogenesis-(1-7)\/Mas axis confers cardiopulmonary protection against lung fibrosis and pulmonary hypertension","volume":"182","author":"Shenoy","year":"2010","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.phrs.2019.04.029_bib1365","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3389\/fimmu.2018.00058","article-title":"Angiotensin-(1-7) Promotes Resolution of Eosinophilic Inflammation in an Experimental Model of Asthma","volume":"9","author":"Magalhaes","year":"2018","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.phrs.2019.04.029_bib1370","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1111\/j.1476-5381.2012.02105.x","article-title":"Suppressing inflammation by inhibiting the NF-kappaB pathway contributes to the neuroprotective effect of angiotensin-(1-7) in rats with permanent cerebral ischaemia","volume":"167","author":"Jiang","year":"2012","journal-title":"Br J Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2019.04.029_bib1375","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.bbrc.2004.11.090","article-title":"Inhibition of NF-kappa B by a cell permeable form of I kappa B alpha induces apoptosis in eosinophils","volume":"326","author":"Fujihara","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib1380","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bcp.2009.04.030","article-title":"Cyclic AMP enhances resolution of allergic pleurisy by promoting inflammatory cell apoptosis via inhibition of PI3K\/Akt and NF-kappaB","volume":"78","author":"Sousa","year":"2009","journal-title":"Biochem Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2019.04.029_bib1385","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1189\/jlb.0809540","article-title":"PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K\/Akt-dependent and NF-kappaB-independent manner","volume":"87","author":"Sousa","year":"2010","journal-title":"J Leukoc Biol."},{"key":"10.1016\/j.phrs.2019.04.029_bib1390","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3389\/fimmu.2017.01596","article-title":"Angiotensin-(1-7) Promotes Resolution of Neutrophilic Inflammation in a Model of Antigen-Induced Arthritis in Mice","volume":"8","author":"Barroso","year":"2017","journal-title":"Front Immunol."},{"key":"10.1016\/j.phrs.2019.04.029_bib1395","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.exger.2016.03.014","article-title":"Behaviour and cognitive changes correlated with hippocampal neuroinflammaging and neuronal markers in female SAMP8, a model of accelerated senescence","volume":"80","author":"Grinan-Ferre","year":"2016","journal-title":"Exp Gerontol."},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib1400","doi-asserted-by":"crossref","first-page":"645","DOI":"10.18632\/aging.101419","article-title":"AVE0991, a nonpeptide analogue of Ang-(1-7), attenuates aging-related neuroinflammation","volume":"10","author":"Jiang","year":"2018","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.phrs.2019.04.029_bib1405","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.neurobiolaging.2013.11.026","article-title":"Triggering receptor expressed on myeloid cells 2 knockdown exacerbates aging-related neuroinflammation and cognitive deficiency in senescence-accelerated mouse prone 8 mice","volume":"35","author":"Jiang","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"4","key":"10.1016\/j.phrs.2019.04.029_bib1410","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s12035-015-9260-9","article-title":"Angiotensin-(1-7) is Reduced and Inversely Correlates with Tau Hyperphosphorylation in Animal Models of Alzheimer\u2019s Disease","volume":"53","author":"Jiang","year":"2016","journal-title":"Mol Neurobiol."},{"issue":"11","key":"10.1016\/j.phrs.2019.04.029_bib1415","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.tips.2015.07.007","article-title":"Resolution Pharmacology: Opportunities for Therapeutic Innovation in Inflammation","volume":"36","author":"Perretti","year":"2015","journal-title":"Trends Pharmacol Sci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819301951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661819301951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:31:31Z","timestamp":1778581891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661819301951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":283,"alternative-id":["S1043661819301951"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2019.04.029","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroinflammation in hypertension: the renin-angiotensin system versus pro-resolution pathways","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2019.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}